Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lifshitz Law PLLC Announces Investigations of Innoviz Technologies Ltd. (NASDAQ: INVZ), Sharecare, Inc. (NASDAQ: SHCR), Amplitude, Inc. (NASDAQ: AMPL), and QuidelOrtho Corporation (NASDAQ: QDEL)

SHCR, INVZ, AMPL

NEW YORK, NY / ACCESSWIRE / June 26, 2024 /

Innoviz Technologies Ltd. (NASDAQ:INVZ)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) Innoviz Technologies overstated the benefits that the Company was likely to derive from its purported contracts, partnerships, and/or collaborations with automotive companies; (ii) as a result, Innoviz Technologies was unlikely to achieve the level of profitability that the Company represented to investors; (iii) accordingly, Innoviz Technologies overstated its business and/or financial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

If you are an INVZ investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Sharecare, Inc. (NASDAQ:SHCR)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose material information that: (i) Sharecare lacked adequate internal controls; and (ii) as a result, the Company's statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.

If you are a SHCR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Amplitude, Inc. (NASDAQ:AMPL)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) Amplitude's land-and-expand strategy was years away from significantly accelerating revenues among its newer client cohorts; (ii) the rapid acceleration in the Company's 2Q21 results resulted from the ephemeral effects of the COVID-19 pandemic which had not continued by the start of the Relevant Period, as Amplitude clients were expanding at a slower pace; and (iii) as a result, Amplitude's business, operations, financial results, and prospects were materially worse than represented to investors during the Relevant Period.

If you are an AMPL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

QuidelOrtho Corporation (NASDAQ:QDEL)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) QuidelOrtho sold more COVID-19 tests to its distributors and pharmacy chain customers than they could resell to healthcare providers and end customers; (ii) excess inventories of COVID-19 tests existed throughout the supply chain; (iii) as a result of the foregoing, QuidelOrtho's distributors and pharmacy chain customers were poised to significantly reduce their COVID-19 test orders; (iv) undisclosed problems created a heightened risk that the Savanna RVP4 Test would experience a delayed commercial launch in the United States; (v) as a result, the Company lacked a reasonable basis for their positive statements about QuidelOrtho's business, financials, and growth trajectory.

If you are a QDEL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

ATTORNEY ADVERTISING.© 2024 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@lifshitzlaw.com

SOURCE: Lifshitz Law PLLC



View the original press release on accesswire.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today